Heinrich, Daniel
Innlandet Hospital Trust
3 papers on CoChatORCID 0000-0002-7086-0562
Most cited papers
- Verified
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine
Prostate Cancer Treatment and ResearchBone health and treatments
Cited by 3,408
- Verified
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Agarwal, N., Azad, A. A., Carles, J., Fay, A. P., Matsubara, N., Heinrich, D., Szczylik, C., De Giorgi, U., Young Joung, J., Fong, P. C. C., et al. (2023) · The Lancet
Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy
Cited by 538
- Verified
Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021
Gillessen, S., Armstrong, A., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Bossi, A., Briganti, A., Bristow, R. G., Bulbul, M., et al. (2022) · European Urology
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 130
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free